Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ).
Dr. Reddy’s Laboratories Ltd. has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. This submission ensures that securities received for dematerialization have been processed and listed appropriately, reflecting the company’s adherence to regulatory compliance and its ongoing commitment to maintaining transparency and trust with its stakeholders.
More about Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of generic medicines. The company is known for its commitment to providing affordable and innovative healthcare solutions.
Average Trading Volume: 81,003
Technical Sentiment Signal: Buy
Current Market Cap: 1030.4B INR
See more data about DRREDDY stock on TipRanks’ Stock Analysis page.